Hepatic Wilson's disease: Initial treatment and long-term management

Current Treatment Options in Gastroenterology

Volumn 8, Issue 6, 2005, Pages 467-472

  Walshe, J M ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA TOCOPHEROL; AMINO ACID; ANTIOXIDANT; ASCORBIC ACID; COPPER; CORTICOSTEROID DERIVATIVE; DIMERCAPROL; EDETATE DISODIUM; PENICILLAMINE; PYRIDOXINE; TETRATHIOMOLYBDATE AMMONIUM; THIOVALINE; TRIENTINE; UNCLASSIFIED DRUG; VITAMIN; ZINC ACETATE; ZINC DERIVATIVE; ZINC SULFATE;

ABDOMINAL PAIN; BILE FLOW; BONE MARROW DEPRESSION; BONE MARROW DISEASE; BRAIN DISEASE; BREAST DISEASE; BURNING SENSATION; CHROMOSOME 13Q; CHROMOSOME MUTATION; COST EFFECTIVENESS ANALYSIS; CUTIS LAXA; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DRUG COST; DRUG DOSE REGIMEN; DRUG POTENTIATION; ELASTOSIS; EPIDERMOLYSIS BULLOSA; EYE DISEASE; FEVER; GALLSTONE; GENETIC ANALYSIS; GOODPASTURE SYNDROME; HOMOZYGOSITY; HUMAN; IMMUNE COMPLEX NEPHRITIS; INJECTION SITE ABSCESS; INJECTION SITE PAIN; IRON DEFICIENCY ANEMIA; KIDNEY DISEASE; LIVER DISEASE; LIVER TRANSPLANTATION; LONG TERM CARE; METABOLIC DISORDER; MOUTH DISEASE; MOUTH ULCER; MUSCLE SPASM; MUSCULOSKELETAL DISEASE; MUTATIONAL ANALYSIS; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; PORTAL HYPERTENSION; REVIEW; SIDE EFFECT; SIDEROBLASTIC ANEMIA; SKIN DEFECT; STOMACH IRRITATION; SWEATING; SYSTEMIC LUPUS ERYTHEMATOSUS; TASTE DISORDER; THORAX DISEASE; THROAT DISEASE; UNITED KINGDOM; UNIVERSITY HOSPITAL; URTICARIA; VOMITING; WELFARE; WILSON DISEASE;

EID: 30344460308     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-005-0033-9     Document Type: Review

References (20)

1. Gibbs K, Walshe JM: Biliary excretion of copper in Wilson's disease. Lancet 1980, 2:538-539.
2. Walshe JM, Yealland M: Wilson's disease: the problem of delayed diagnosis. J Neurol Neurosurg Psychiat 1992, 55:692-696.
3. Cumings JN: The copper and iron content of brain and liver in the normal and hepatolenticular degeneration. Brain 1948, 71:410-415.
4. Walshe JM: Penicillamine: a new oral therapy for Wilson's disease.Amer J Med 1956, 21:487-495.
5. Schouwink G: De hepato-cerebrale degenerate [MD thesis]. Amsterdam: University of Amsterdam; 1961.
6. Hoogenraad TU, Van Hattum J, Van den Hammer CJ: Management of Wilson's disease. With zinc sulphate. Experience in a series of 27 patients. J Neurol Sci 1987, 77:137-146.
7. Walshe JM: Management of penicillamine nephropathy; a new chelating agent. Lancet 1969, 2:1401-1402.
8. Walshe JM: Copper, its role in the pathogenesis of liver disease. Semin Liver Dis 1984, 4:252-263.
9. Starzl TE, Iwatsuki S, Van Thiel DH, et al.: Evolution of liver transplantation. Hepatology 1982, 2:614-636.
10. Sutcliffe RP, Maguire DD, Muiesan P, et al.: Liver transplantation for Wilson's disease; long results and quality of life assessment. Transplantation 2003, 15:1003-1006.
11. Walshe JM: Unithiol in Wilson's disease. Brit Med J 1985, 290:673-674.
12. Gibbs KR, Walshe JM: Penicillamine and pyridoxine requirements in man. Lancet 1966, 1:175-179.
13. Walshe JM: Controversies. Penicillamine; treatment of first choice for patients Wilson's disease. Mov Disord 1999, 14:175-179.
14. Brewer GJ, Johnson VD, Dick RD, et al.: Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy. Hepatology 2000, 31:364-370.
15. Brewer GJ, Dick RD, Johnson VD, et al.: Treatment of Wilson's disease with zinc. XVI: treatment during the pediatric years. J Lab Clin Med 2001, 137:191-198.
16. Walshe JM: Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylenetetramine dihydrochloride. Quart J Med 1973, 42:441-452.
17. Brewer GJ, Dick RD, Johnson VD, et al.: Treatment of Wilson's disease with ammonium tetrathiomolybdate. Initial therapy in 17 neurologically affected patients. Arch Neurol 1994, 51:545-554.
18. Walshe JM: Tetrathiomolybdate (MoS4) as an anticopper agent in man. In Orphan Diseases and Orphan Drugs. Edited by Scheinberg IH, Walshe JM. Manchester: University Press; 1986: 76-85.
19. Roberts EA, Schilsky MI: A Practice guideline on Wilson disease. Hepatology 2003, 37:1475-1492.
20. Walshe JM, Waldenstrom E, Sams V, et al.: Abdominal malignancies in patients with Wilson's disease. Quart J Med 2003, 96:657-662.